April 11, 2026 03:50 pm (IST)
Emerging markets affect Dr Reddy's Laboratories' December quarter performance
Hyderabad, Feb 9 (IBNS) Dr Reddy's Laboratories Ltd announced its consolidated financial results on Tuesday for the quarter ended December 31, 2015, where it posted consolidated revenue of ₹39.7 billion, up 3 per cent from the same period in 2014, largely because the healthy performance in North America Generics (NAG), Europe and India were partially offset by emerging markets, which were impacted by unfavorable macro-economic conditions.
Revenues from the Global Generics segment for the reported quarter was ₹33.6 billion, up 7 per cent from the year-ago quarter, primarily driven by North America, Europe and India.
Revenues from the Pharmaceutical Services and Active Ingredients (PSAI) segment was ₹5.1 billion in the reported quarter, and declined by 17 per cent from the same quarter a year ago.
Support Our Journalism
We cannot do without you.. your contribution supports unbiased journalism
IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.
Support objective journalism for a small contribution.
Latest Headlines
Nissan Motor India marks major network expansion with 54 new customer touchpoints in Q1 of CY 2026
Fri, Apr 10 2026
Groww shares climb 5%, extend rally for third session
Fri, Apr 10 2026
From Oracle layoffs in the US to an India comeback: Couple’s emotional story goes viral
Fri, Apr 10 2026
South Asia remains fastest-growing region; India continues as growth engine: World Bank
Thu, Apr 09 2026
AI impact: Dell cuts 11,000 jobs in strategic workforce trim
Thu, Apr 09 2026
TCS gains ahead of Q4 earnings; street eyes growth signals
Thu, Apr 09 2026
Meesho shares soar 14% — stock now 55% above IPO price!
Thu, Apr 09 2026
